Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest.
about
Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel B55α-PP2A mutations in A ...... hibitor-induced growth arrest.
@en
Novel B55α-PP2A mutations in A ...... hibitor-induced growth arrest.
@nl
type
label
Novel B55α-PP2A mutations in A ...... hibitor-induced growth arrest.
@en
Novel B55α-PP2A mutations in A ...... hibitor-induced growth arrest.
@nl
prefLabel
Novel B55α-PP2A mutations in A ...... hibitor-induced growth arrest.
@en
Novel B55α-PP2A mutations in A ...... hibitor-induced growth arrest.
@nl
P2093
P2860
P356
P1433
P1476
Novel B55α-PP2A mutations in A ...... hibitor-induced growth arrest.
@en
P2093
Chien-Shing Chen
Geoffrey Shouse
Rosalia de Necochea-Campion
Saied Mirshahidi
P2860
P304
61081-61092
P356
10.18632/ONCOTARGET.11209
P407
P577
2016-08-11T00:00:00Z